Linking director compensation and corporate value through stock options with stock-based compensation
First written in FY2017-Q1. 18 of 25 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-07-22.
- FY2026-H1AdvancedAnnual report
「Based on a resolution of the Board of Directors at a meeting held on 26 June 2025, the Company disposed of 16,494 treasury shares as restricted stock compensation for directors and executive officers with titles.」
Under the restricted stock compensation plan, 16,494 treasury shares were disposed of for directors and executive officers with titles. - FY2025-H1AdvancedAnnual report
「Based on a resolution of the Board of Directors at a meeting held on 25 June 2024, the Company disposed of 14,337 treasury shares as restricted stock compensation for directors and executive officers with titles.」
Under the restricted stock compensation plan introduced in FY2024, 14,337 treasury shares were disposed of for directors and executive officers with titles. - FY2024ReframedAnnual report
「At a meeting held on 9 May 2024, the Board of Directors resolved to introduce a restricted stock compensation plan for officers as a new plan replacing the existing stock-based compensation option plan, and submitted the related proposal to the Company’s 87th annual general meeting of shareholders held on 25 June 2024, where it was approved.」
The stock-based compensation option plan for directors and executive officers with titles was abolished and changed to a restricted stock compensation plan for directors. - FY2024-Q1SoftenedAnnual report
「The options are being issued to promote more rapid management focused on sustainably increasing corporate value, strengthen the alignment between the remuneration of directors and executive officers with titles and the Company’s corporate value, align their interests with those of shareholders, and increase their motivation and morale to improve performance and raise the share price. 5 directors of the Company: 98 options 3 executive officers with titles of the Company: 37 options Total number of share options Not more than 135 options.」
For 2023, the Company also resolved to issue stock-based compensation options for 5 directors and 3 executive officers with titles. The maximum is 135 options, down from 177 in the prior year. - FY2023AdvancedAnnual report
「For the 2022 stock options granted during the consolidated fiscal year, the grantees were 5 directors and 3 executive officers with titles of the Company, the options covered 17,700 common shares, and the grant date was 26 August 2022.」
Full-year disclosure was made of the grant of 17,700 stock-based compensation options for 2022 to 5 directors and 3 executive officers with titles. - FY2023-Q2AdvancedAnnual report
「Resolution date: 29 July 2022; categories and number of grantees (people): 5 directors of the Company; 3 executive officers with titles; number of share options (options)*: 177; class, details and number of underlying shares (shares)*: 17,700 common shares.」
A total of 177 share options representing 17,700 underlying shares were issued on 26 August 2022 under the 2022 stock-based compensation plan for 5 directors and 3 executive officers with titles. - FY2023-Q1AdvancedAnnual report
「At a meeting held on 29 July 2022, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, the offering terms for share options to be allotted as stock-based compensation options to its directors, excluding outside directors, and its executive officers with titles, and resolved to solicit subscriptions from those intending to subscribe for the options.」
For the 2022 stock-based compensation options, the Company resolved to issue up to a total of 177 options, comprising 132 for 5 directors and 45 for 3 executive officers with titles. The maximum increased from 175 options in the prior year, and the structure continued to cover executive officers with titles in addition to directors. - FY2022-Q2AdvancedAnnual report
「Resolution date: 30 July 2021; categories and number of grantees (people): 6 directors of the Company; 3 executive officers with titles; number of share options (options)*: 175; class, details and number of underlying shares (shares)*: 17,500 common shares.」
The terms disclosed for the 2021 stock-based compensation options for 6 directors and 3 executive officers with titles were 175 options representing 17,500 underlying shares. This progressed from the prior quarter’s resolution to issue the options to disclosure of the issuance details on 26 August 2021. - FY2022-Q1RaisedAnnual report
「The options are being issued to promote more rapid management focused on sustainably increasing corporate value, strengthen the alignment between the remuneration of directors and executive officers with titles and the Company’s corporate value, align their interests with those of shareholders, and increase their motivation and morale to improve performance and raise the share price.」
For the 2021 stock-based compensation options, the Company resolved to expand eligibility from 6 directors to include 3 executive officers with titles, and to issue up to 175 options. - FY2021AdvancedAnnual report
「For the 2020 stock options granted during the consolidated fiscal year, the grantees were 8 directors of the Company, the options covered 20,000 common shares, and the grant date was 27 August 2020.」
A total of 20,000 stock-based compensation options for 2020 were granted to 8 directors. The exercise conditions were changed to also cover the loss of office of an executive officer at or above the rank of managing executive officer, in addition to directors. - FY2021-Q2AdvancedAnnual report
「Resolution date: 31 July 2020; categories and number of grantees (people): 8 directors of the Company; number of share options (options)*: 200; class, details and number of underlying shares (shares)*: 20,000 common shares.」
The quarterly report disclosed the terms of the 2020 stock-based compensation options approved in FY2021-Q1: 200 options for 8 directors, representing 20,000 underlying shares. - FY2021-Q1AdvancedAnnual report
「The stock options are being issued to more rapidly promote management focused on sustainably increasing corporate value. The purpose is to strengthen the linkage between director compensation and the Company's corporate value, align the interests of directors with those of shareholders, and increase their motivation and morale to improve performance and increase the share price.」
At a meeting held on 31 July 2020, the Board of Directors approved the offering terms for up to 200 2020 share options for 8 directors, excluding outside directors. The allotment date was set as 27 August 2020, and the exercise period as 28 August 2020 to 26 August 2055. - FY2020-Q2AdvancedAnnual report
「Resolution date: 30 July 2019; categories and number of grantees (people): 8 directors of the Company; number of share options (options)*: 125; class, details and number of underlying shares (shares)*: 12,500 common shares; exercise period*: from 29 August 2019 to 27 August 2054.」
The quarterly report confirms that 125 share options representing 12,500 underlying shares were issued for the 2019 stock-based compensation plan for 8 directors. - FY2020-Q1AdvancedAnnual report
「At a meeting held on 30 July 2019, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, the offering terms for share options to be allotted to its directors as stock-based compensation options, and resolved to solicit subscriptions from those intending to subscribe for the options. The total number of share options shall not exceed 125.」
For the 2019 stock-based compensation options, the Company resolved to issue up to 125 options for 8 directors, excluding 2 outside directors. The allotment date was set as 28 August 2019, and the exercise period as 29 August 2019 to 27 August 2054. - FY2019AdvancedAnnual report
「2018 stock options: categories and number of grantees: 7 directors of the Company; number of stock options by class of shares: 7,600 common shares; grant date: 29 August 2018.」
A total of 7,600 stock-based compensation options for 2018 were granted to 7 directors. A total of 3,900 shares from the 2016 and 2017 grants were exercised, demonstrating the plan’s operating results. - FY2019-Q2AdvancedAnnual report
「Number of share options (options)*: 76; class, details and number of underlying shares (shares)*: common shares, 7,600; exercise period*: from 30 August 2018 to 28 August 2053.」
A total of 76 share options representing 7,600 underlying shares were issued for the 2018 stock-based compensation plan for 7 directors. - FY2019-Q1AdvancedAnnual report
「The stock options are being issued to more rapidly promote management focused on sustainably increasing corporate value. The purpose is to strengthen the linkage between director compensation and the Company's corporate value, align the interests of directors with those of shareholders, and increase their motivation and morale to improve performance and increase the share price.」
At a meeting held on 31 July 2018, the Board of Directors approved the offering terms for up to 76 2018 share options for 7 directors, excluding outside directors. The allotment date was set as 29 August 2018, and the exercise period as 30 August 2018 to 28 August 2053. - FY2018AdvancedAnnual report
「For the 2016 stock options, the 25,100 shares outstanding at the end of the previous consolidated fiscal year declined by 3,200 shares exercised and 600 shares forfeited, leaving 21,300 shares outstanding at the end of the current consolidated fiscal year. In addition, 9,300 shares were granted under the 2017 stock options and remained outstanding after vesting.」
A total of 9,300 stock-based compensation options were granted for 2017, while 3,200 shares under the 2016 grant were exercised and 600 shares forfeited. - FY2018-Q2AdvancedAnnual report
「The share options issued during the second quarter accounting period were as follows: Number of share options (options): 93; number of underlying shares (shares): 9,300; exercise period: from 26 August 2017 to 24 August 2052.」
A total of 93 stock-based compensation options, representing 9,300 underlying shares, were actually issued for 2017. - FY2018-Q1AdvancedAnnual report
「The stock options are being issued to more rapidly promote management focused on sustainably increasing corporate value. The purpose is to strengthen the linkage between director compensation and the Company's corporate value, align the interests of directors with those of shareholders, and increase their motivation and morale to improve performance and increase the share price.」
At a meeting held on 28 July 2017, the Board of Directors resolved the offering terms for the 2017 share options. The options were for 8 directors, excluding outside directors, with a maximum of 93 options, each covering 100 shares, and an allotment date of 25 August 2017. - FY2017RestatedAnnual report
「For stock options outstanding during the consolidated fiscal year, the 2016 stock options covered 25,100 shares granted, with no exercises, leaving 25,100 shares outstanding.」
Full-year disclosure covers the grants and outstanding balances for the 2016 stock-based compensation options and the exercise status of options granted in prior years. - FY2017-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows.」
A total of 251 stock options (representing 25,100 underlying shares) were actually issued as stock-based compensation options intended to align directors’ remuneration with corporate value. The exercise period runs from 26 August 2016 to 24 August 2051. - FY2017-Q1First statedAnnual report
「The stock options are being issued to more rapidly promote management focused on sustainably increasing corporate value. The purpose is to strengthen the linkage between director compensation and the Company's corporate value, align the interests of directors with those of shareholders, and increase their motivation and morale to improve performance and increase the share price.」
The Company decided to issue stock options with stock-based compensation for 9 directors, with a maximum of 251 options. Each option represents 100 shares, the exercise price is ¥1 per share, the allotment date is 25 August 2016, and the exercise period is from 26 August 2016 to 24 August 2051.